Register entry

Xiamen LP Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
3
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Xiamen LP Pharmaceutical Co., Ltd.2010 Wengjiao West Road, Xiamen, Fujian 361027, China (CHN)Analytical testing, Labelling, Finished drug manufacture, Packaging3013002864544415908
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: ANDA 3.

Dosage formNDCs
tablet, extended release3
RouteNDCs
oral3
Labeller name on the listingNDCs
xiamen lp pharmaceutical co., ltd.3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
Clonidine HydrochlorideClonidine Hydrochloridetablet, extended release, oral71034-001ANDA
Pramipexole Dihydrochloride Extended-ReleasePramipexole Dihydrochloridetablet, extended release, oral71034-002ANDA
Pramipexole Dihydrochloride Extended-ReleasePramipexole Dihydrochloridetablet, extended release, oral71034-003ANDA
Neighbours

Registered in the same town

2
Compare

Comparable companies in China

Enquiry

Common questions

Is Xiamen LP Pharmaceutical Co., Ltd. FDA approved?
Xiamen LP Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Xiamen LP Pharmaceutical Co., Ltd.'s drugs manufactured?
The FDA register lists Xiamen. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does Xiamen LP Pharmaceutical Co., Ltd. make?
3 products are listed under Xiamen LP Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as tablet, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.